CEREBRAL CAVERNOUS MALFORMATION

This adverse event was reported 45 times

These drugs are most commonly taken by patients reporting CEREBRAL CAVERNOUS MALFORMATION:

# Drug Count
0 CYCLOPHOSPHAMIDE 12
1 CYCLOPHOSPHAMIDE FOR INJECTION 12
2 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 12
3 ETOPOSIDE 12
4 METHOTREXATE SODIUM 10
5 METHOTREXATE 9
6 CARBOPLATIN 8
7 THIOTEPA 8
8 BEVACIZUMAB 6
9 TOCILIZUMAB 5
See all common drugs associated with CEREBRAL CAVERNOUS MALFORMATION

CEREBRAL CAVERNOUS MALFORMATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 THYROTROPIN ALFA 1 0.0010
1 THIOTEPA 8 0.0008
2 ANTIHEMOPHILIC FACTOR HUMAN 1 0.0007
3 DONANEMAB-AZBT 2 0.0007
4 INSULIN ASPART INJECTION 1 0.0004
5 ZINC SULFATE INJECTION, 1 0.0003
6 ZINC SULFATE INJECTION 1 0.0003
7 DEFERIPRONE 1 0.0003
8 EDOXABAN TOSYLATE 2 0.0003
9 SCOPOLAMINE 1 0.0003
See all drugs enriched for association with CEREBRAL CAVERNOUS MALFORMATION